FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study
Clinical trial NCT03110510 · WITHDRAWN
Trial details
- NCT number
- NCT03110510
- Sponsor
- Samsung Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-06
- Primary completion
- 2019-09-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.